Fellow eye changes in optic neuritis correlate with the risk of multiple sclerosis

Multiple Sclerosis

Volumn 15, Issue 8, 2009, Pages 928-932

  Klistorner, Alexander ^a,e   Arvind, H ^a   Nguyen, T ^b   Garrick, R ^c   Paine, M ^b   Graham, S ^a   Yiannikas, C ^d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e NONE   (Australia)

Author keywords

Electrophysiology; Fellow eye; Multiple sclerosis; Optic neuritis; Subclinical; VEP

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ELECTROPHYSIOLOGY; EVOKED VISUAL RESPONSE; FEMALE; HIGH RISK PATIENT; HUMAN; LATENT PERIOD; MALE; MULTIPLE SCLEROSIS; OPTIC NEURITIS; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR;

ADULT; BRAIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; EVOKED POTENTIALS; EYE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OPTIC NEURITIS; PHOTIC STIMULATION; REACTION TIME; RISK ASSESSMENT; SPINAL CORD; TIME FACTORS; VISUAL ACUITY;

EID: 69549088567     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509105228     Document Type: Article

References (24)

1. Filippi, M, Rocca, M. MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system. J Neurol 2005; 252(Suppl.): v16-v24.
2. Allen, IV, McQuaid, S, Mirakhur, M, Nevin, G. Pathological abnormalities in the normal-appearing white matter in multiple sclerosis. Neurol Sci 2001; 22: 141-144.
3. Miller, DH, Thompson, AJ, Fillipi, M. Magnetisation resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis. J Neurol 2003; 250: 1407-1419.
4. Fernando, K, Tozer, DJ, Miszkiel, KA, et al. Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2005; 128: 2911-2925.
5. Iannucci, G, Tortorella, C, Rovaris, N, Sormani, MP, Comi, G, Fillipi, M. Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation. Am J Neuroradiol 2000; 21: 1034-1038.
6. Tintore, M, Rovira, A, Rio, J, et al. Is optic neuritis more benign than other first attacks in multiple sclerosis? Ann Neurol 2005; 57: 210-215.
7. Waxman, SG. Retinal involvement in multiple sclerosis. Neurology 2007; 69: 1562-1563.
8. Beck, RW, Kupersmith, MJ, Cleary, PA, Katz, B. Fellow eye abnormalities in acute unilateral optic neuritis. Ophthalmology 1992; 100: 691-698.
9. Yiannikas, C, Walsh, JC. The variation of the pattern shift visual evoked response with the size of the stimulus field. Electroencephalogr Clin Neurophysiol 1983; 55: 427-435.
10. Yiannikas, C, Walsh, JC. The variation of the pattern shift visual evoked response with the size of the stimulus field. Electroencephalogr Clin Neurophysiol 1983; 55: 427-435.
11. Riggs, LA, Wooten, BR. Electrical measures and psychophysical data on human vision. In: Jameson, D, Hurvich, LM, (eds), Handbook of sensory physiology. New York: Springer-Verlag; 1972. p. 690-731.
12. Baseler, HA, Sutter, EE, Klein, SA, Carney, T. The topography of visual evoked response properties across the visual field. Electroencephalogr Clin Neurophysiol 1994; 90: 65-81.
13. Hood, DC, Zhang, X, Greenstein, VC, et al. An interocular comparison of the multifocal VEP: A possible technique for detecting local damage to the optic nerve. Invest Ophthalmol Vis Sci 2000; 41: 1580-1587.
14. Klistorner, AI, Graham, SL, Grigg, JR, Billson, FA. Multifocal topographic visual evoked potential: Improving objective detection of local visual field defects. Invest Ophthalmol Vis Sci 1998; 39: 937-950.
15. Fraser, C, Klistorner, A, Graham, SL, Garrick, R, Billson, F, Grigg, JR. Multifocal visual evoked potential latency analysis: Predicting progression to multiple sclerosis. Arch Neurol 2006; 63: 846-850.
16. Klistorner, A, Fraser, C, Garrick, R, Graham, SL, Arvind, H. Correlation between full-field and multifocal VEPs in optic neuritis. Doc Ophthalmol 2007; 116: 19-27.
17. Klistorner, A, Graham, SL, Fraser, C, et al. Electrophysiological evidence for heterogeneity of lesions in optic neuritis. Invest Ophthalmol Vis Sci 2007; 48: 4549-4556.
18. Hood, DC, Odel, JG, Zhang, X. Tracking the recovery of local optic nerve function after optic neuritis: A multifocal VEP study. Invest Ophthalmol Vis Sci 2000; 41: 4032-4038.
19. Klistorner, A, Arvind, H, Nguyen, T, et al. Inflammation, demyelination and axonal loss in post-acute optic neuritis. Ann Neurol 2008; 61: 325-331.
20. Beck, RW, Trobe, JD, Moke, PS, et al. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: Experience of the optic neuritis treatment trial. Arch Ophthalmol 2003; 121: 944-949.
21. Klistorner, A, Graham, SL. Electroencephalogram-based scaling of multifocal visual evoked potentials: Effect on intersubject amplitude variability. Invest Ophthalmol Vis Sci 2001; 42: 2145-2152.
22. Graham, SL, Klistorner, A. The diagnostic significance of the multifocal pattern visual evoked potential in glaucoma. Curr Opin Ophthalmol 1999; 10: 140-146.
23. Brusa, A, Jones, SJ, Plant, GT. Long-term remyelination after optic neuritis. Brain 2001; 124: 468-479.
24. Jones, SJ, Brusa, A. Neurophysiological evidence for longterm repair of MS lesions: Implications for axon protection. J Neurol Sci 2003; 206: 193-198.